PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25180704-6	2014	Within the study period, highest PPRs were found for the fixed combination of clenbuterol/ambroxol (between 374-575 per 10,000 children) and the inhaled short acting beta-2-agonist salbutamol (between 378-527 per 10,000 children).	Albuterol	181-191	potassium calcium-activated channel subfamily M regulatory beta subunit 2	Homo sapiens	166-172	
25180704-7	2014	Highest relative PPR increase was found for oral salbutamol (approx.	Albuterol	49-59	PPR1	Homo sapiens	17-20	
25180704-8	2014	39-fold) whereas the most distinct decrease was found for oral long-acting beta-2-agonist clenbuterol (-97%).	Clenbuterol	90-101	potassium calcium-activated channel subfamily M regulatory beta subunit 2	Homo sapiens	75-81